Trial
NCT06603818
Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Microsatellite Stable Metastatic Colorectal Cancer
Intervention
Tiragolumab
Why stopped
The trial is closing due to findings from a related study, prompting the sponsor to discontinue development and end this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-19